|Articles|July 1, 2014
- BioPharm International-07-01-2014
- Volume 27
- Issue 7
BioPharm International, July 2014 Issue (PDF)
Click the title above to open the BioPharm International July 2014 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 11 years ago
Benefits and Risks of Drug Information on Social Mediaover 11 years ago
Health Systems Raise the Bar on Reimbursing New Drugsover 11 years ago
Microbioreactors Increase Productivityover 11 years ago
Quantitative Mycoplasma DNA Offers Quality Controlover 11 years ago
Moving the Needle on Healthcareover 11 years ago
Analyzing Proteins Using SEC, MALS, and UHPLCover 11 years ago
Brazil's Phytotherapic Drug Market and Regulationover 11 years ago
Industry Seeks Clearer Standards for Track and Traceover 11 years ago
Supplier Audit Program Marks ProgressNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
2
Rentschler’s Time Capsule and How it Symbolizes European Biotech Progress
3
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
4
Analytics, Automation, and Quality Driving the Next Era of Drug Development
5
